Table 1.
Demographics and Cancer History.
| Characteristic | Total (N = 146) |
|---|---|
| Age at Diagnosis, years | 59.5 (11.73)a |
| Body Mass Index, kg/m2 | 31.0 (9.86)a |
| Site of Origin | |
| Uterus | 78 (53.4) |
| Ovary | 68 (46.6) |
| Histology | |
| Carcinoma | 127 (87.0) |
| Sarcoma/Other | 19 (13.0) |
| Stage | |
| I | 32 (21.9) |
| II | 7 (4.8) |
| III | 68 (46.6) |
| IV | 37 (25.3) |
| Unknown | 2 (1.4) |
| Grade | |
| Low | 43 (29.5) |
| High | 98 (67.1) |
| Unknown | 5 (3.1) |
| Estrogen Receptor (ER) Expression | |
| ER-positive | 90 (61.6) |
| ER-negative | 9 (6.2) |
| Unknown | 47 (32.2) |
| Measurable Disease at AI Initiation | |
| Yes | 108 (74.0) |
| No | 32 (21.9) |
| Not documented | 6 (4.1) |
| Prior Radiation Therapy | |
| Yes | 44 (30.1) |
| No | 102 (69.9) |
| Number of Prior Lines of Chemotherapy | 2.2 (1.9)a |
Data presented as n (%) unless otherwise noted.
AI = aromatase inhibitor.
a
Mean (SD).